GETTYSBURG, Pa., March 18, 2015 (GLOBE NEWSWIRE) -- Fact Sheet | New articles, resources, and presentations related to Psychiatry & Managed Care now available at no charge via PsychU's online community and knowledge center at www.psychu.org.
- 66% Of All Medicaid Beneficiaries Enrolled In Managed Care Plans In 2014 (News) — In 2014, about 66% of Medicaid beneficiaries, or 43.5 million of the total 66.5 million beneficiaries for that year, were enrolled in a Medicaid managed care plan run by one of 184 private health insurers.
- 40% Of Commercial Insurance Reimbursements Tied To Performance Incentives (News) — About 40% of commercial health plan reimbursements to in-network provider organizations in 2014 are linked to value-oriented initiatives intended to improve the quality of services or to cut waste. This compares to 11% in 2013.
- Medicare Bets Big On Pay-For-Value (Perspective) — A few days ago our team touched on the importance of building and maintaining payer relationships in a market that is shifting from fee-for-service (FFS) with no ties to performance, to one based on value and population. While this movement from "pay for volume" to "pay for value" in health care contracting has been happening for years, it's been more of a trickle – but this year, I think the torrent has started.
- "Following The Money" In Specialty Care Management (Featured Article) — Our focus yesterday was on prioritization of your business development dollars by using market mapping to prioritize the influence of specific customers in the market.
- Where Does Mental Health Fit In The World Of ACOs? (Perspective) — Where does mental health fit into the world of Accountable Care Organizations (ACOs)? For all that ACOs are talked about as the "latest and greatest" in care coordination, discussion of mental health care is often absent from the conversation. The goal of the ACO model is to better coordinate care for patients – in hopes of increasing the quality of care and lowering costs.
- Managed Care Enrollment Of Duals Almost Doubles Between 2011 & 2014 (Featured Article) — Reporting on dual eligibles tends to focus on the lurching start by the Centers for Medicare and Medicaid Services (CMS) Medicaid-Medicare dual demonstration projects. Often missed in these discussions is the parallel—but much faster—shift of dual eligible into traditional and long term Medicaid managed care.
- Narrow Networks Happening By Design & By Default (Featured Article) — "Narrow network." It's a term that's getting a lot of attention now – and a concept that every manager in the health and human service field should be familiar with.
- How Does Managed Care Affect Delivery Of Medicaid Rehabilitation Option Services? (Featured Article) — Earlier this week a reader, responding to our coverage of more stringent controls on who receives Idaho Medicaid rehabilitation option services now that the state has moved to a managed behavioral health delivery system, posed the question – "How does the inclusion of Medicaid rehabilitation option services in managed care change these services elsewhere?". To answer, we must first define Medicaid rehabilitation option services and look at how states choose to deliver them.
- Medicare ACOs Improved Patient Experience For Patients With Multiple Chronic Conditions (News) — Medicare beneficiaries with multiple chronic conditions and high predicted Medicare spending who received care through a Medicare Accountable Care Organization (ACO) reported receiving more timely access to care than they had through the Medicare fee-for-service (FFS) system.
- CMS Launches $840 Million Value-Based Health Care Transformation Initiative (News) — On October 23, 2014, the federal Centers for Medicare & Medicaid Services (CMS) launched a new health care transformation initiative to help clinical professionals and hospitals move from volume-based to valued-based services. Through this initiative, CMS will provide up to $840 million over the next four years to support 150,000 clinical professionals in the development of comprehensive quality improvement strategies.
See what other content is available on the PsychU community by visiting: http://www.psychu.org/
The Importance Of Adherence To Long-Term Success In Schizophrenia
A new educational program available to clinical and executive teams across the country
A live presentation and discussion on medication adherence in schizophrenia, including:
- The importance of adherence in this population
- The relationship between adherence and relapse
- Factors associated with poor adherence and barriers to adherence
- Outcomes and hospitalization rates associated with degrees of adherence
- The role communication plays in improving adherence
This and other programs are available at no charge through the PsychU "Request A Presentation" program
___________________________________________________________________________________________________________________________________________
About PsychU
PsychU is a new online community and knowledge center dedicated to understanding, sharing, and evolving best practices in mental health treatment. Through the exchange of information, experience, and ideas, PsychU members aim to shift the current trajectory of mental health care and improve the future outlook for individuals with mental illnesses.
The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Users seeking medical advice should consult with their physician or other healthcare professional.
PsychU is supported by Otsuka America Pharmaceutical, Inc. and Lundbeck, L.L.C., committed supporters of the mental health treatment community. No CME credits are available through any of the resources provided by PsychU. The PsychU online community and website is managed by OPEN MINDS. Some of the contributors may be paid consultants for Otsuka America Pharmaceuticals, Inc. and/or Lundbeck, L.L.C. Medical writing support provided by Oxford PharmaGenesis, Inc. who received payment for their services from Otsuka America Pharmaceutical, Inc. and Lundbeck, L.L.C.
For additional questions or information, contact the PsychU Team at 855-559-6829 or info@psychu.org.